Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 13;117(11):188-193.
doi: 10.3238/arztebl.2020.0188.

Intermittent Claudication and Asymptomatic Peripheral Arterial Disease

Affiliations
Review

Intermittent Claudication and Asymptomatic Peripheral Arterial Disease

Gerhard Rümenapf et al. Dtsch Arztebl Int. .

Abstract

Background: The conservative treatment of peripheral arterial disease (PAD), as recommended in current guidelines, encompasses measures such as lifestyle modification and risk-factor management. In addition, in patients with vasogenic intermittent claudication (IC), it is recommended that patients first be given drugs to improve perfusion and undergo supervised gait training. Revascularization is not recommended for asymptomatic persons, but it is considered mandatory for patients with critical ischemia. In this article on conservative and revascularizing treatment strategies for IC, we address the following questions: whether all treatment options are available, how effective they are, and whether the reality of treatment for IC in Germany corresponds to what is recommended in the guidelines.

Methods: In 2014, the German Society for Angiology carried out a comprehensive literature search in order to prepare a new version of the S3 guideline on PAD. This literature search was updated up to 2018, with identical methods, for the present review.

Results: The benefit of lifestyle modification and risk factor treatment is supported by high-level evidence ( evidence level I, recommendation grade A ). The distance patients are able to walk without pain is increased by drug therapy as well (evidence level IIb), but the therapeutic effect is only moderate. Supervised exercise training (SET), though supported by high-level evidence (I, A), is of limited efficacy, availability, and applicability, and patient compliance with it is also limited. In patients with IC, revascularization leads to complete relief of symptoms more rapidly than gait training, and its long-term benefit is steadily improving owing to advances in medical technology. A combination of arterial revascularization and gait training yields the best results. In a clinical trial, patients with IC who underwent combined therapy increased the distance they could walk without pain by 954 m in six months, compared to 407 m in a group that underwent gait training alone.

Conclusion: In the treatment of vasogenic IC, SET and drugs to increase perfusion are now giving way to revascularization, which is more effective. As far as can be determined, SET is not currently implemented at all in the German health care system. It would be desirable for SET to be more available and more widely used, both to sustain the benefit of revascularization over the long term and to lower the general cardiovascular risk.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Short-segment occlusion of the right superficial femoral artery. Structured supervised exercise training can improve collateral circulation.
Figure 2
Figure 2
Strong collateral circulation between the deep femoral artery and the popliteal artery is hindered by upstream high-grade stenosis of the common femoral artery, meaning that exercise training is unable to have a sufficient effect.

Comment in

  • Spinal Cord Stimulation as Therapy Option.
    Reining M, Kretzschmar M. Reining M, et al. Dtsch Arztebl Int. 2020 Oct 2;117(40):676. doi: 10.3238/arztebl.2020.0676a. Dtsch Arztebl Int. 2020. PMID: 33357353 Free PMC article. No abstract available.
  • Cardiovascular Rehabilitation Overlooked.
    Schlitt A, Dörr G, Schwaab B. Schlitt A, et al. Dtsch Arztebl Int. 2020 Oct 2;117(40):676. doi: 10.3238/arztebl.2020.0676b. Dtsch Arztebl Int. 2020. PMID: 33357354 Free PMC article. No abstract available.
  • More Amputations with Intervention.
    Böhner H, Kröger K. Böhner H, et al. Dtsch Arztebl Int. 2020 Oct 2;117(40):677. doi: 10.3238/arztebl.2020.0677a. Dtsch Arztebl Int. 2020. PMID: 33357355 Free PMC article. No abstract available.
  • Walking Training of a Vascular Sports Group.
    Kiesewetter H. Kiesewetter H. Dtsch Arztebl Int. 2020 Oct 2;117(40):677. doi: 10.3238/arztebl.2020.0677b. Dtsch Arztebl Int. 2020. PMID: 33357356 Free PMC article. No abstract available.

References

    1. Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimators of prevalence and risk factors for peripheral arterial disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329–1340. - PubMed
    1. Alberts MJ, Bhatt DL, Mas JL, et al. Three-year follow-up and event rates in the international reductuion of atherothrombosis for continued health registry. Eur Heart J. 2009;30:2318–2326. - PMC - PubMed
    1. Lawall H, Huppert P, Espinola-Klein C, Rümenapf G. The diagnosis and treatment of peripheral arterial vascular disease. Dtsch Arztebl Int. 2016;113:729–736. - PMC - PubMed
    1. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II) J Vasc Surg. 2007;45:S5–S67. - PubMed
    1. Conte MS, Pomposelli FB, Clair DG, et al. Societey for Vascular Surgery Lower Extremity Guidelines Writing Group, Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg. 2015;61:2S–41S. - PubMed